Insider Trading activities of Collegium Pharmaceutical, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Collegium Pharmaceutical, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Collegium Pharmaceutical, Inc since year 2005. Table 2 shows the detailed insider transactions of Collegium Pharmaceutical, Inc since 2005. The reporting company's ticker symbol is COLL. The reporting company's CIK number is 1267565.
The total value of stock buying since 2005 is $13,316,951.
The total value of stock sales since 2005 is $35,535,861.
The total value of stock option exercises since 2005 is $34,398.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Collegium Pharmaceutical, Inc (COLL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 2,000,000 $34,680,000 0 $0
2017-11 0 $0 54,601 $855,861 3,761 $1,052
2017-10 0 $0 0 $0 1,811 $6,121
2017-05 10,000 $91,800 0 $0 0 $0
2017-01 0 $0 0 $0 3,013 $1,446
2016-08 2,375 $25,151 0 $0 0 $0
2016-04 0 $0 0 $0 13,604 $25,779
2015-05 1,100,000 $13,200,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Collegium Pharmaceutical, Inc insiders (COLL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-08 Hirsch David (Director) Sale 1,000,000 17.34 17,340,000
2017-12-08 Longitude Venture Partners L.p. (10% Owner) Sale 1,000,000 17.34 17,340,000
2017-11-21 Fleming Alison B (Chief Technology Officer) Sale 572 19.00 10,868
2017-11-21 Fleming Alison B (Chief Technology Officer) Option Ex 572 .28 160
2017-11-17 Fleming Alison B (Chief Technology Officer) Sale 4,029 17.00 68,493
2017-11-17 Fleming Alison B (Chief Technology Officer) Option Ex 3,189 .28 892
2017-11-15 Heffernan Michael Thomas (Chairman, President and CEO) Sale 50,000 15.53 776,500
2017-10-25 Fleming Alison B (Chief Technology Officer) Option Ex 1,811 3.38 6,121
2017-05-12 Brannelly Paul (Executive Vice President & CFO) Buy 10,000 9.18 91,800
2017-01-31 Heffernan Michael Thomas (Chairman, President and CEO) Option Ex 3,013 .48 1,446
2016-08-12 Fallon John A. (Director) Buy 2,375 10.59 25,151
2016-04-05 Heffernan Michael Thomas (Chairman, President and CEO) Option Ex 13,604 1.90 25,779
2015-05-12 Hirsch David (Director) Buy 200,000 12.00 2,400,000
2015-05-12 Every Nathan R (10% Owner) Buy 150,000 12.00 1,800,000
2015-05-12 Heron Patrick J (Director) Buy 150,000 12.00 1,800,000
2015-05-12 Freund John Gordon (Director) Buy 150,000 12.00 1,800,000
2015-05-12 Kaneko Yasunori (10% Owner) Buy 150,000 12.00 1,800,000
2015-05-12 Enright Patrick G (10% Owner) Buy 200,000 12.00 2,400,000
2015-05-12 Coulter James G Buy 100,000 12.00 1,200,000

Insider trading activities including stock purchases, stock sales, and option exercises of COLL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Collegium Pharmaceutical, Inc (symbol COLL, CIK number 1267565) see the Securities and Exchange Commission (SEC) website.